Rare & Autoimmune

Autoimmune Disease

Non-invasive biomarkers, peer-reviewed and procedure-free.

For autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis and related cholangiopathies, Perspectum's biomarkers replace diagnostic ERCP and serial biopsy wherever the science allows. MRCP+ is the imaging endpoint of choice in three current PSC trials.

The point: keep the diagnostic insight; remove the procedural patient burden.